Boxer Capital, Llc Odonate Therapeutics, Inc. (ODTC) insider trading activity

Boxer Capital, LLC is > 10% Shareholder of Odonate Therapeutics, Inc.. Currently has a direct ownership of 4.21 Million shares of ODTC, which is worth approximately $71.9 Billion. The most recent transaction as insider was on Nov 24, 2021, when has been sold 200,000 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $314,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.21M

0% 3M change

0% 12M change

Total Value Held $71.9 Billion

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2021	SELL Open market or private sale	$314,000 $1.57 p/Share	200,000 Reduced 4.54%	4,207,086 Common Stock
Nov 22 2021	SELL Open market or private sale	$310,000 $1.55 p/Share	200,000 Reduced 4.34%	4,407,086 Common Stock
Nov 19 2021	SELL Open market or private sale	$276,000 $1.84 p/Share	150,000 Reduced 3.15%	4,607,086 Common Stock
Nov 18 2021	SELL Open market or private sale	$487,500 $1.95 p/Share	250,000 Reduced 4.99%	4,757,086 Common Stock
Nov 17 2021	SELL Open market or private sale	$1,302,000 $2.17 p/Share	600,000 Reduced 10.7%	5,007,086 Common Stock
Dec 30 2020	BUY Open market or private purchase	$1,746,000 $17.46 p/Share	100,000 Added 1.75%	5,607,086 Common Stock
Dec 28 2020	BUY Open market or private purchase	$5,103,000 $17.01 p/Share	300,000 Added 5.17%	5,507,086 Common Stock
Sep 29 2020	BUY Open market or private purchase	$1,717,760 $14.08 p/Share	122,000 Added 2.29%	5,207,086 Common Stock
Sep 28 2020	BUY Open market or private purchase	$1,214,396 $13.03 p/Share	93,200 Added 1.8%	5,085,086 Common Stock
Sep 09 2020	BUY Open market or private purchase	$1,232,720 $15.2 p/Share	81,100 Added 1.6%	4,991,886 Common Stock
Sep 08 2020	BUY Open market or private purchase	$276,172 $14.69 p/Share	18,800 Added 0.38%	4,910,786 Common Stock
Sep 04 2020	BUY Open market or private purchase	$1,862,739 $14.89 p/Share	125,100 Added 2.49%	4,891,986 Common Stock
Aug 28 2020	BUY Open market or private purchase	$20,000,003 $14.25 p/Share	1,403,509 Added 22.75%	4,766,886 Common Stock
Jun 26 2019	BUY Open market or private purchase	$9,999,990 $26.0 p/Share	384,615 Added 10.26%	3,363,377 Common Stock
Dec 26 2018	BUY Open market or private purchase	$311,750 $12.47 p/Share	25,000 Added 0.83%	2,978,762 Common Stock
Dec 21 2018	BUY Open market or private purchase	$1,347,000 $13.47 p/Share	100,000 Added 3.27%	2,953,762 Common Stock
Oct 24 2018	BUY Open market or private purchase	$394,849 $14.72 p/Share	26,824 Added 0.93%	2,853,762 Common Stock
Mar 26 2018	BUY Open market or private purchase	$754,096 $22.41 p/Share	33,650 Added 1.18%	2,826,938 Common Stock
Mar 23 2018	BUY Open market or private purchase	$1,028,914 $23.96 p/Share	42,943 Added 1.51%	2,793,288 Common Stock
Mar 22 2018	BUY Open market or private purchase	$490,143 $20.94 p/Share	23,407 Added 0.84%	2,750,345 Common Stock
Dec 06 2017	BUY Open market or private purchase	$9,999,984 $24.0 p/Share	416,666 Added 13.25%	2,726,938 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

BCL